Randall Moreadith insider trades

Open-market stock purchases and sales by Randall Moreadith, Chief Scientific Officer at Serina Therapeutics, Inc, from SEC Form 4 filings since Jun 30, 2025.

Recent trades

DateStockTradeValue
May 21, 2026SER Serina Therapeutics, IncBought (not open market)—
Mar 23, 2026SER Serina Therapeutics, IncSold$18.6K
Mar 23, 2026SER Serina Therapeutics, IncBought (not open market)—
Mar 19, 2026SER Serina Therapeutics, IncSold$97.5K
Mar 19, 2026SER Serina Therapeutics, IncBought (not open market)—
Feb 3, 2026SER Serina Therapeutics, IncBought (not open market)—
Feb 2, 2026SER Serina Therapeutics, IncSold$19.7K
Feb 2, 2026SER Serina Therapeutics, IncBought (not open market)—
Jan 28, 2026SER Serina Therapeutics, IncSold$23.2K
Jan 28, 2026SER Serina Therapeutics, IncBought (not open market)—
Jan 22, 2026SER Serina Therapeutics, IncBought (not open market)—
Jan 22, 2026SER Serina Therapeutics, IncSold$7.4K
Jan 21, 2026SER Serina Therapeutics, IncSold$6K
Jan 21, 2026SER Serina Therapeutics, IncBought (not open market)—
Jan 20, 2026SER Serina Therapeutics, IncSold$6.1K
Jan 20, 2026SER Serina Therapeutics, IncBought (not open market)—
Jan 14, 2026SER Serina Therapeutics, IncBought (not open market)—
Jan 14, 2026SER Serina Therapeutics, IncSold$2.7K
Jan 13, 2026SER Serina Therapeutics, IncSold$13.5K
Jan 13, 2026SER Serina Therapeutics, IncBought (not open market)—
Jan 8, 2026SER Serina Therapeutics, IncSold$35K
Jan 8, 2026SER Serina Therapeutics, IncBought (not open market)—
Dec 23, 2025SER Serina Therapeutics, IncSold$10.7K
Dec 23, 2025SER Serina Therapeutics, IncBought (not open market)—
Dec 22, 2025SER Serina Therapeutics, IncSold$15.2K

Companies traded

  • SER Serina Therapeutics, Inc: 41 sales, last May 21, 2026

Get free alerts when Randall Moreadith files a new trade →